Clorox (CLX) Reports Q2 Revenue About In-Line with Views
Get Alerts CLX Hot Sheet
Price: $91.60 -1.57%
EPS Growth %: +30.6%
Financial Fact:
Cost of products sold: 803M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +30.6%
Financial Fact:
Cost of products sold: 803M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Clorox (NYSE: CLX) reported Q2 EPS of $1.77, $0.54 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.43 billion.
Diluted EPS results reflect a benefit of 61 cents from a significantly lower effective tax rate in the second quarter as a result of U.S. corporate tax reform.
GUIDANCE:
Clorox sees FY2018 EPS of $6.17-$6.37, versus the consensus of $6.16.
For earnings history and earnings-related data on Clorox (CLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share